← All Neuroone Medical Technologies CORP filings

Neuroone Medical Technologies CORP Form 4 insider transactions

NASDAQ
NMTC
Neuroone Medical Technologies CORP
Form 4: NeuroOne Medical Technologies Officer Disposes of Shares to Cover Tax Obligations
Steve Mertens, Chief Technology Officer of NeuroOne Medical Technologies, disposed of 252 shares of common stock on February 29, 2024, to satisfy tax obligations.
NASDAQ
NMTC
Neuroone Medical Technologies CORP
Form 4: NeuroOne Medical Technologies CEO David Rosa Disposes of Shares to Cover Tax Obligations
NeuroOne Medical Technologies CEO David Rosa disposed of 2,239 shares of common stock on February 29, 2024, to cover tax obligations related to equity awards.
NASDAQ
NMTC
Neuroone Medical Technologies CORP
Form 4: NeuroOne Medical Technologies Executive Sells Shares to Cover Tax Obligations
Mark Christianson, Business Development Director at NeuroOne Medical Technologies, disposed of 90 shares of common stock on February 29, 2024, to cover tax obligations.